ARCHIVES

Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices

This article is from The Cancer Letter archive.

Vol. 19 No. 34 | September 3, 1993

Download PDF Visit The Full Archive

Related Articles

Dugan Head ACCC, Yarbro President Elects; Amos Honored

March 18, 1983

Duke University Settles 11 Medical Malpractice Cases Related to Potti’s trials

December 9, 2011

New NIH Chief Splits with Predecessors, HEW Brass, Opposes “Balance,” Likes Cancer Program

October 24, 1975

1991 Bypass Budget Would Fund 50 Percent Of Competing Grants

May 26, 1989

ImClone Founding CEO Samuel Waksal Charged With Securities Fraud, Conspiracy, Perjury

June 14, 2002

Phase III Lung and Pancreatic Cancer Trials Are Stopped

April 30, 2010